Please login to the form below

Not currently logged in

Excellence in Communications - Payers/Policy Makers

Sponsored by

Back to results



by Hanover Communications for HEART UK

Summary of work

Cardiovascular disease (CVD) is one of the nation’s biggest killers and high cholesterol is one of the biggest risk factors of CVD. As a small charity trying to punch above its weight, HEART UK, the Cholesterol Charity, with its agency Hanover Communications, has campaigned to reach policy makers with the message that CVD prevention must be prioritised. Activity has focused in particular on driving implementation of NHS Health Checks and raising awareness of the urgent need for improved diagnosis of inherited cardiac conditions. Through evidence-building and targeted policy maker and NHS engagement, the charity has highlighted best practice in CVD prevention and secured policy commitments designed to drive progress in the roll-out of prevention and diagnosis programmes. The Government’s CVD Outcomes Strategy, published in 2013, represented a full delivery of our early campaigning objectives with its pledges around implementing and evaluating the NHS Health Checks Programme and driving better detection of inherited cardiac conditions. HEART UK now has a place at the table in all official policy implementation structures and continued campaigning for progress against the Strategy’s ambitions means CVD prevention is now embedded in the new public health structures.

Judges comments

This is a sustained and driven campaign that has to compete with much larger organisations in a crowded policy space, showing notable endurance. The direct patient impact of improved Familial Hypercholesterolemia testing is impressive and the campaign has a very clear and driven strategy.


Standardised packaging of tobacco products - by Cancer Research UK and Action on Smoking & Health

Highly commended

Beat It Now! - by Just:: Health Communications for Meningitis Now


HEART UK - by Hanover Communications for HEART UK

Saving lives, averting costs - by Incisive Health for Cancer Research UK

Breaking the taboo: putting incontinence on the NHS quality agenda for the first time - by MHP Communications for The expert group on LUTS, supported by Astellas

Category Sponsors

Dr Richard White, MP PhD, Oxford PharmaGenesis - Communiqué Judge

Key dates

Entry deadline 11 March 2022
Extended entry deadline 18 March 2022
(additional fee applies)
Judging days May 2022
Awards Ceremony 7th July 2022

Contact information:

For sponsorship opportunities:
Sales Team
Tel: +44 (0)1372 414200

General event enquiries:
Debbie Tuesley
Tel: +44 (0)1372 414243

Entry and dinner booking enquiries:
Saoirse Meenaghan
Tel: 01372 414253